Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemia. [electronic resource]
Producer: 19930915Description: 343-50 p. digitalISSN:- 1042-8194
- Adolescent
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bone Marrow Diseases -- chemically induced
- Bone Marrow Transplantation
- Colitis -- chemically induced
- Combined Modality Therapy
- Conjunctivitis -- chemically induced
- Cytarabine -- administration & dosage
- Drug Administration Schedule
- Female
- Humans
- Leukemia, Myeloid, Acute -- drug therapy
- Male
- Middle Aged
- Pancreatitis -- chemically induced
- Peripheral Nervous System Diseases -- chemically induced
- Remission Induction
- Salvage Therapy
- Treatment Outcome
- Vidarabine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.